Clinical Trial Update: A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety, tolerability, and pharmacokinetics of escalating concentrations of a topical ocular formulation BL1332 in healthy volunteers add…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Pain

Drugs mentioned

• BL1332

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Ocular Pain | Phase 1 | Status: ACTIVE_NOT_RECRUITING